AbCellera Biologics Inc. (ABCL)

AbCellera Biologics Revenue

AbCellera Biologics had revenue of $4.05M in the quarter ending June 30, 2026, a decrease of -76.29%. This brings the company's total for the last twelve months to $66.17M, up 101.28% year-over-year. In the year 2025, AbCellera Biologics had annual revenue of $75.13M with 160.56% growth. That makes AbCellera Biologics the 25,853rd largest company in the world by revenue and 3,568th in the United States.

• Revenue (ttm): $66.17M
• Revenue Growth: +101.28%
• P/S Ratio: 59.94
• Revenue / Employee: $117,740
• Employees: 562
• Market Cap: 3.97B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Licensing and Royalty 46.92M 62.5%
• Research Fees 27.21M 36.2%
• Milestone Payments 1.00M 1.3%

Fiscal year ended Dec 31, 2025 See the full AbCellera Biologics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	75.13M	46.30M	160.56%
Dec 31, 2024	28.83M	-9.19M	-24.17%
Dec 31, 2023	38.03M	-447.40M	-92.17%
Dec 31, 2022	485.42M	110.22M	29.38%
Dec 31, 2021	375.20M	142.05M	60.92%
Dec 31, 2020	233.16M	221.54M	1,907.88%
Dec 31, 2019	11.61M	2.78M	31.49%
Dec 31, 2018	8.83M	-	-

Data Source: Fiscal.ai Last updated: Aug 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error